An in vitro potency assay using nicotinic acetylcholine receptor binding works well with antivenoms against Bungarus candidus and Naja naja. Ratanabanangkoon K, Simsiriwong P, Pruksaphon K, Tan KY, Chantrathonkul B, Eursakun S, Tan CH. Sci Rep. 2018 Jun 26;8(1):9716. doi: 10.1038/s41598-018-27794-3. PMID: 29946111

26 Jun 2018
0
0
Ratanabanangkoon K, Simsiriwong P, Pruksaphon K, Tan KY, Chantrathonkul B, Eursakun S, Tan CH.
Sci Rep. 2018 Jun 26;8(1):9716. doi: 10.1038/s41598-018-27794-3.
PMID: 29946111

 

Tags

Share this

Related Posts

The molecular basis of mucopolysaccharidosis type I in two Thai patients. Ketudat Cairns JR, Keeratichamroen S, Sukcharoen S, Champattanachai V, Ngiwsara L, Lirdprapamongkol K, Liammongkolkul S, Srisomsap C, Surarit R, Wasant P, Svasti J*. Southeast Asian J Trop Med Public Health. 2005 Sep;36(5):1308-12.
01 Sep 2005
0

The molecular basis of mucopolysaccharidosis type I in two Thai patients. Ketudat Cairns JR, Keeratichamroen S, Sukcharoen S, Champattanachai V, Ngiwsara L, Lirdprapamongkol K, Liammongkolkul S, Srisomsap C, Surarit R, Wasant P, Svasti J*. Southeast Asian J Trop Med Public Health. 2005 Sep;36(5):1308-12.

The molecular basis of mucopolysaccharidosis type I in two Thai patients. Ketudat Cairns JR, Keeratichamroen S, Sukcharoen S, Champattanachai V, Ngiwsara L, Lirdprapamongkol K, Liammongkolkul S, Srisomsap C, Surarit R, Wasant P, Svasti J*. Southeast Asian J Trop Med Public Health. 2005 Sep;36(5):1308-12.
View More

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)
20 Sep 2023
0

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial) Siripongboonsitti T, Ungtrakul T, Tawinprai K, Auewarakul C, Chartisathian W, Jansala T, Julsawad R, Soonklang K, Mahanonda N, Mahidol C Phytomedicine. 2023;119:155018.
View More